
- Directed evolution of AAV vectors in the liver, eye and kidney
- Experimental & bioinfomatic high-throughput screening pipelines
Contact

- Analysis of AAV next-generation sequencing data (Illumina, PacBio)
- Establishment of user-friendly AAV alignment and analysis tools
Contact

- In vivo AAV library screens in major organs
-
Contact

- In vivo AAV library screens in major organs
-
Contact

- Analysis of AAV NGS data
- Development of methods and bioinformatics pipelines for NGS data analysis
Contact

- Development of novel gene therapy vectors derived from Bocavirus
- Engineering of synthetic circuits to control bocavirus vector production
Contact

- Engineering of synthetic AAV capsids through peptide display & shuffling
- Directed evolution of AAV capsids in multiple major organs in animal models
Contact

- Design and synthesis of hybrid AAV - origami (Virogami) nanoparticles
- Targeted in vivo gene delivery using Virogami particles
Contact

- Design and synthesis of hybrid AAV - origami (Virogami) nanoparticles
- Targeted in vivo gene delivery using Virogami particles
Contact

- Genetic code expansion using AAV vectors
- AAV vector retargeting through combinatorial peptide display
Contact

- Synthetic AAV ITRs for enhanced vector persistence
Contact

- Novel in vivo AAV capsid evolution technologies
- AAV-based CRISPR/Cas applications including SARS_CoV-2
Contact

- Combinatorial CRISPR/RNAi strategies against HBV/HDV
Contact

- AAV engineering for expression of broadly neutralizing antibodies
Contact